Ubisol-Q10 Prevents Glutamate-Induced Cell Death by Blocking Mitochondrial Fragmentation and Permeability Transition Pore Opening

Santosh Kumari, Suresh L. Mehta, Gaolin Zheng Milledge, Xinyu Huang, Haining Li, Peng LiInternational Journal of Biological Sciences 2016 · DOI

Abstract

Mitochondrial dysfunction and oxidative stress are the major events that lead to the formation of mitochondrial permeability transition pore (mPTP) during glutamate-induced cytotoxicity and cell death. Coenzyme Q10 (CoQ10) has widely been used for the treatment of mitochondrial disorders and neurodegenerative diseases. Comparing to traditional lipid-soluble CoQ10, water soluble CoQ10 (Ubisol-Q10) has high intracellular and intra-mitochondrial distribution. The aims of the present study are to determine the neuroprotective effects of Ubisol-Q10 on glutamate-induced cell death and to explore its functional mechanisms. HT22 neuronal cells were exposed to glutamate. Cell viability was measured and mitochondrial fragmentation was assessed by mitochondrial imaging. The mPTP opening was determined by mitochondrial membrane potential and calcium retention capacity. The results revealed that the anti-glutamate toxicity effects of Ubisol-Q10 was associated with its ability to block mitochondrial fragmentation, to maintain calcium retention capacity and mitochondrial membrane potential, and to prevent mPTP formation, AIF release, and DNA fragmentation. We concluded that Ubisol-Q10 protects cells from glutamate toxicity by preserving the integrity of mitochondrial structure and function. Therefore, adequate CoQ10 supplementation may be beneficial in preventing cerebral stroke and other disorders that involve mitochondrial dysfunction.

Introduction

Glutamate is the brain's primary excitatory neurotransmitter, but in excess—a condition called excitotoxicity—it becomes a potent neurotoxin. This process is a hallmark of acute brain injuries (like stroke and traumatic brain injury) and chronic conditions (like Alzheimer’s and Parkinson’s). The "executioner" in this process is often the mitochondrion. Under glutamate stress, mitochondria undergo excessive fission (fragmentation), lose their membrane potential, and open pores (mPTP) that leak pro-apoptotic proteins.

While Coenzyme Q10 (CoQ10) is a known antioxidant and mitochondrial stabilizer, its traditional oil-soluble form has notoriously poor bioavailability. This study investigates whether Ubisol-Q10, a water-soluble formulation with 20–30 times better cellular uptake, can effectively intervene in this death cascade by stabilizing mitochondrial structural integrity and preventing the release of death-inducing factors.

Methods

The researchers utilized HT22 murine hippocampal neuronal cells to model excitotoxicity. The experimental workflow included:

  • Induction of Stress: Cells were exposed to 4 mM glutamate to induce oxidative stress and cell death.
  • Treatment: Cells were pre-treated with varying concentrations of Ubisol-Q10 (10–25 µg/ml).
  • Mitochondrial Morphometrics: Using MitoTracker Red and confocal microscopy, the team quantified mitochondrial shapes using a "form factor" to distinguish between healthy tubular networks and fragmented "dots."
  • Functional Assays: Measurements included Reactive Oxygen Species (ROS) via DHE fluorescence, mitochondrial membrane potential via JC-1 dye, and calcium retention capacity using Calcium Green-5N.
  • Protein Analysis: Western blotting and immunostaining tracked the translocation of Drp1 (a fission protein) to the mitochondria and AIF (Apoptosis-Inducing Factor) to the nucleus.

Key Results and Insights

The study demonstrated that Ubisol-Q10 significantly mitigates the damage caused by glutamate.

Survival and Morphology

Glutamate exposure reduced cell viability to approximately 20%. Pre-treatment with 15 µg/ml of Ubisol-Q10 restored viability to 87%. Visually, glutamate caused cells to shrink and lose their characteristic neuronal morphology, while Ubisol-Q10 treatment maintained healthy cell structures.

Ubisol-Q10 restores cell viability and morphology in glutamate-treated HT22 cells.

Mitochondrial Stabilization

  • Blocking Fission: Glutamate toxicity hijacks the cell's natural division machinery, causing the protein Drp1 to move to the mitochondrial surface. Ubisol-Q10 specifically blocks this translocation, preventing excessive fragmentation and keeping mitochondria in their healthy, tubular state.
  • Calcium and Membrane Potential: Mitochondria normally act as calcium buffers. Glutamate destroys this capacity, but Ubisol-Q10 restored the mitochondria's ability to sequester calcium pulses and maintained the essential membrane potential.
  • AIF-Dependent Death: Glutamate-induced death in these cells was mediated by Apoptosis-Inducing Factor (AIF) moving to the nucleus. Ubisol-Q10 effectively "locked" AIF inside the mitochondria, preventing DNA fragmentation.

Beyond Antioxidant Activity

While Ubisol-Q10 reduced ROS, it outperformed the standard antioxidant Trolox in survival assays. This suggests its protective effect involves direct structural stabilization of mitochondrial membranes rather than just "mopping up" free radicals.

Limitations and Future Directions

While promising, the study has limitations:

  • Therapeutic Window: The research focused on 24-hour pre-treatment. Future work must establish if Ubisol-Q10 is effective when administered after a glutamate insult, as would occur in clinical stroke scenarios.
  • Model Complexity: HT22 cells lack the complex glia-neuron interactions of a whole brain. In vivo animal models are necessary to validate these findings.
  • Molecular Mechanism: The exact molecular interaction between Ubisol-Q10 and the Drp1 fission machinery remains to be fully elucidated.

In conclusion, Ubisol-Q10 represents a high-bioavailability therapeutic candidate for neuroprotection by preserving mitochondrial integrity and function.

Summary updated

Abstract

Mitochondrial dysfunction and oxidative stress are the major events that lead to the formation of mitochondrial permeability transition pore (mPTP) during glutamate-induced cytotoxicity and cell death. Coenzyme Q10 (CoQ10) has widely been used for the treatment of mitochondrial disorders and neurodegenerative diseases. Comparing to traditional lipid-soluble CoQ10, water soluble CoQ10 (Ubisol-Q10) has high intracellular and intra-mitochondrial distribution. The aims of the present study are to determine the neuroprotective effects of Ubisol-Q10 on glutamate-induced cell death and to explore its functional mechanisms. HT22 neuronal cells were exposed to glutamate. Cell viability was measured and mitochondrial fragmentation was assessed by mitochondrial imaging. The mPTP opening was determined by mitochondrial membrane potential and calcium retention capacity. The results revealed that the anti-glutamate toxicity effects of Ubisol-Q10 was associated with its ability to block mitochondrial fragmentation, to maintain calcium retention capacity and mitochondrial membrane potential, and to prevent mPTP formation, AIF release, and DNA fragmentation. We concluded that Ubisol-Q10 protects cells from glutamate toxicity by preserving the integrity of mitochondrial structure and function. Therefore, adequate CoQ10 supplementation may be beneficial in preventing cerebral stroke and other disorders that involve mitochondrial dysfunction.
BibTeX
@article{kumari2016ubisol,
  author = {Santosh Kumari and Suresh L. Mehta and Gaolin Zheng Milledge and Xinyu Huang and Haining Li and Peng Li},
  title = {{Ubisol-Q10 Prevents Glutamate-Induced Cell Death by Blocking Mitochondrial Fragmentation and Permeability Transition Pore Opening}},
  journal = {International Journal of Biological Sciences},
  year = {2016},
  doi = {10.7150/ijbs.13589},
}
Figure